The loss of APC leads to constitutive activation of the Wnt/β-catenin signaling pathway that sustains CSC survival and promotes the clonal exclusion of WT-ISC through the secretion of Wnt antagonists in the tumor microenvironment (TME) [79,80,81]. This evidence concerns the gene APC and neoplasm.